bioAffinity Technologies (BIAF) Institutional Ownership $1.37 -0.06 (-4.20%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for bioAffinity Technologies (NASDAQ:BIAF)CurrentInstitutional OwnershipPercentage1.64%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$49.39KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$31.39K Get BIAF Insider Trade Alerts Want to know when executives and insiders are buying or selling bioAffinity Technologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here bioAffinity Technologies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/9/2024Renaissance Technologies LLC22,967$50K0.0%-38.8%0.197% 8/8/2024 Ground Swell Capital LLC22,864$49K0.0%N/A0.196% (Data available from 1/1/2016 forward) BIAF Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BIAF shares? During the previous two years, the following institutional investors and hedge funds held shares of bioAffinity Technologies shares: Renaissance Technologies LLC ($50K), Ground Swell Capital LLC ($49K).Learn more on BIAF's institutional investors. What percentage of bioAffinity Technologies stock is owned by institutional investors? 1.64% of bioAffinity Technologies stock is owned by institutional investors. Learn more on BIAF's institutional investor holdings. Which institutional investors have been buying bioAffinity Technologies stock? The following institutional investors have purchased bioAffinity Technologies stock in the last 24 months: Ground Swell Capital LLC ($22.86K). How much institutional buying is happening at bioAffinity Technologies? Institutional investors have bought a total of 22,864 shares in the last 24 months. This purchase volume represents approximately $49.39K in transactions. Which bioAffinity Technologies major shareholders have been selling company stock? The following institutional investors have sold bioAffinity Technologies stock in the last 24 months: Renaissance Technologies LLC ($14.53K). How much institutional selling is happening at bioAffinity Technologies? Institutional investors have sold a total of 14,533 shares in the last 24 months. This volume of shares sold represents approximately $31.39K in transactions. Related Companies Vacasa Institutional Ownership Luna Innovations Institutional Ownership SPAR Group Institutional Ownership Lichen China Institutional Ownership Fluent Institutional Ownership IZEA Worldwide Institutional Ownership Inotiv Institutional Ownership MoneyHero Institutional Ownership Li-Cycle Institutional Ownership Mobiquity Technologies Institutional Ownership This page (NASDAQ:BIAF) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
